Schoen Eric — SEC insider filings
SEC reporting owner CIK 1532303. 9 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2020-09-17 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 34,500 shares, $142,655 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 61,800 shares, $238,468 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 59,800 shares @ $3.86 ($230,828) in FILANA THERAPEUTICS, INC., filed 2024-12-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | Chief Financial Officer | 9 | 4 legs · 34,500 sh · $142,655 | 2 legs · 61,800 sh · $238,468 | 10 |
Insider filings — Schoen Eric
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | FILANA THERAPEUTICS, INC. (FLNA) | Purchase (P): 20,000 @ $0.42 | EDGAR |
| 2025-04-21 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | CASSAVA SCIENCES INC (SAVA) | Option exercise (M): 50,000 @ $1.18 · Sale (S): 2,000 @ $3.82 · Sale (S): 59,800 @ $3.86 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-09-09 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | CASSAVA SCIENCES INC (SAVA) | Option exercise (M): 1,500 @ $22 · Grant/award (A): 7,920 (derivative) @ $0 · Grant/award (A): 800 (derivative) @ $0 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | CASSAVA SCIENCES INC (SAVA) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-08-16 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 2,500 @ $19.95 | EDGAR |
| 2020-09-17 | 4 | CASSAVA SCIENCES INC (SAVA) | Purchase (P): 10,000 @ $7.03 · Purchase (P): 2,000 @ $7.04 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1532303 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs